Literature DB >> 29614356

Application of Gelatin Sponge Impregnated with a Mixture of 3 Drugs to Intraoperative Nerve Root Block to Promote Early Postoperative Recovery of Lumbar Disc Herniation.

Jin Peng Du1, Yong Fan2, Ding Jun Hao3, Yun Fei Huang2, Jia Nan Zhang2, Lei Hong Yuan2.   

Abstract

OBJECTIVE: To observe effect of application of gelatin sponge impregnated with a mixture of 3 drugs to intraoperative nerve root block to promote early postoperative recovery of lumbar disc herniation.
METHODS: Retrospective analysis was performed of 265 patients with single-level lumbar disc herniation from January 2013 to October 2017. Patients were divided into intervention and control groups based on intraoperative application of gelatin sponge impregnated with a mixture of 3 drugs. All patients underwent unilateral minimally invasive surgical transforaminal lumbar interbody fusion. Clinical data, including bedridden period, postoperative hospital stay, visual analog scale scores for low back pain and leg pain, Japanese Orthopaedic Association score, postoperative satisfaction questionnaire results, and therapeutic effect, were collected.
RESULTS: There were 136 cases in the intervention group and 129 cases in the control group. The intervention group had significantly shorter bedridden period and postoperative hospital stay than control group (P < 0.05). Visual analog scale scores for low back pain and leg pain at postoperative days 1-10 were significantly lower in the intervention group compared with control group (P < 0.05). The Japanese Orthopaedic Association score at postoperative day 6 and satisfaction at 72 hours postoperatively were significantly higher in the intervention group than in control group (P < 0.05). Clinical effect at postoperative day 6 was significantly better in the intervention group than control group (P < 0.05).
CONCLUSIONS: Application of gelatin sponge impregnated with a mixture of 3 drugs to intraoperative nerve root block can significantly promote early postoperative recovery of lumbar disc herniation and has great short-term clinical efficacy.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gelatin sponge; Lumbar disc herniation; MIS-TLIF; Nerve root block

Mesh:

Substances:

Year:  2018        PMID: 29614356     DOI: 10.1016/j.wneu.2018.03.170

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  5 in total

1.  The feasibility and safety of cocktail treatment of triple anti-inflammatory agents loaded with gelatin sponge promotes early recovery after posterior percutaneous endoscopic cervical discectomy.

Authors:  Peng Zou; Xiaoping Zhang; Rui Zhang; Jun-Song Yang; Lei Chu; Xiang-Fu Wang; Jian-Min Wei; Xin Chai; Yuan-Ting Zhao; Bo Liao
Journal:  J Orthop Surg Res       Date:  2022-05-26       Impact factor: 2.677

2.  Application of Drug and Exercise Intervention in Postoperative Rehabilitation: A New Evaluation of Health Coordination Effect.

Authors:  Weide Shao; Qian Wang; Tian Liao; Qiaoyin Tan
Journal:  Front Surg       Date:  2022-04-21

3.  Intraoperative anti-inflammatory drugs combined with no drainage after MIS-TLIF in the treatment of recurrent lumbar disc herniation: an RCT.

Authors:  Jinpeng Du; Junsong Yang; Liang Yan; Lequn Shan; Wentao Wang; Yong Fan; Dingjun Hao; Dageng Huang
Journal:  J Orthop Surg Res       Date:  2021-01-07       Impact factor: 2.359

4.  Effect and Clinical Value of Protective Motivation Intervention Rehabilitation Model on Pain Perception and Dysfunction in Patients with Lumbar Disc Herniation: Based on a Retrospective Cohort Study.

Authors:  Xingbang Liu; Yong He
Journal:  Comput Math Methods Med       Date:  2022-08-30       Impact factor: 2.809

5.  Efficacy of gelatin sponge impregnated with ropivacaine on postoperative pain after transforaminal lumbar interbody fusion: a comparative study.

Authors:  Shanxi Wang; Bo Wang; Xiaojun Yu; Tian Ma; Mubotu C Ntambale; Jiyuan Yan; Qing Ding; Ruizhuo Zhang; Hua Wu; Chaoxu Liu
Journal:  BMC Musculoskelet Disord       Date:  2021-08-06       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.